行情

CBIO

CBIO

Catalyst Biosciences
NASDAQ

实时行情|Nasdaq Last Sale

1.250
-0.100
-7.41%
盘后: 1.270 +0.02 +1.60% 16:00 11/26 EST
开盘
1.330
昨收
1.350
最高
1.340
最低
1.240
成交量
67.13万
成交额
--
52周最高
7.55
52周最低
1.240
市值
3,926.21万
市盈率(TTM)
-0.4051
分时
5日
1月
3月
1年
5年
Catalyst Biosciences 将出席 Piper Sandler 第 33 届年度虚拟医疗保健会议
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare C...
GlobeNewswire · 5天前
Raymond James Downgrades Catalyst Biosciences to Market Perform
Raymond James analyst Timur Ivannikov downgrades Catalyst Biosciences (NASDAQ:CBIO) from Outperform to Market Perform.
Benzinga · 11/15 09:50
70 Biggest Movers From Friday
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Benzinga · 11/15 09:40
Looking Into Catalyst Biosciences's Return On Capital Employed
Catalyst Biosciences (NASDAQ:CBIO) brought in sales totaling $2.30 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 26.69%, resulting in a loss of $25.23 million.
Benzinga · 11/12 16:22
Altamira Therapeutics 和 SOC Telemed 引领医疗保健赢家; Oncorus 和 Acutus Medical 成为主要输家
Gainers: Altamira Therapeutics (NASDAQ:CYTO) +82%, SOC Telemed (NASDAQ:TLMD) +16%, Sundial Growers (NASDAQ:SNDL) +16%, Beyond Air (NASDAQ:XAIR) +15%, IM Cannabis (NASDAQ:IMCC) +13%. Losers: Oncorus (NASDAQ:ONCR) -43%, Acutus Medical (NASDAQ:AFIB) -43%, Cat...
Seekingalpha · 11/12 16:03
What Is Happening With Catalyst Biosciences Shares Today?
Benzinga · 11/12 14:24
Coupang, KE Holdings, WM Technology among premarket losers' pack
Oncorus (NASDAQ:ONCR) -38% after presents Phase 1 clinical trial of ONCR-177 at the Society for Immunotherapy of Cancer's 36th Annual Meeting Catalyst Biosciences CBIO -31% on Q3 earnings release Team TISI -30% on Q3 earnings release.
Seekingalpha · 11/12 13:58
Catalyst Biosciences EPS misses by $0.14, beats on revenue
Catalyst Biosciences (NASDAQ:CBIO): Q3 GAAP EPS of -$0.80 misses by $0.14. Revenue of $2.3M (+158.4% Y/Y) beats by $1.8M. Shares -31.63% PM. Press Release Cash, cash equivalents and, investments, as
Seekingalpha · 11/12 13:46
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CBIO最新的财务预测,通过CBIO每股收益,每股净资产,每股现金流等数据分析Catalyst Biosciences近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
60.00%买入
40.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CBIO价格均价为11.67,最高价位16.00,最低价为4.000。
最高16.00
均价11.67
最低4.000
现价1.250
EPS
实际EPS
预期EPS
-0.69-0.52-0.34-0.17
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 103
机构持股: 2,043.25万
持股比例: 65.05%
总股本: 3,140.97万
类型机构数股数
增持
9
67.44万
建仓
14
83.01万
减持
30
229.21万
平仓
15
84.59万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+2.30%
制药与医学研究
+0.44%
高管信息
Non-Executive Chairman/Independent Director
Augustine Lawlor
President/Chief Executive Officer/Director
Nassim Usman
Chief Financial Officer/Senior Vice President - Finance/Chief Accounting Officer
Seline Miller
Senior Vice President
Tom Knudsen
Chief Scientific Officer
Grant Blouse
Director
Jeanne Jew
Independent Director
Errol De Souza
Independent Director
Andrea Hunt
Independent Director
Geoffrey Ling
Independent Director
Sharon Tetlow
Independent Director
Edward Williams
公告日期
每股分红
除权日期
2015/08/04
每股分红:USD 0.5692
2015/08/20
CBIO 简况
Catalyst Biosciences Inc(原名:Targacept Inc)是一家研究和临床开发生物制药公司。该公司专注于补体和凝血系统疾病的医疗需求。其蛋白酶工程平台展开两个后期临床项目,包括 marzeptacog alfa(MarzAA)。MarzAA是一种皮下(SQ)给药的工程凝血因子VIIa(FVIIa),用于治疗A型或B型抑制剂血友病患者患有罕见出血性疾病受试者的偶发性出血。用于因子VII缺乏症、Glanzmann Thrombasthenia和血友病抑制剂患者A的MarzAA正处于临床试验阶段,用于预防性Hemlibra治疗发作性出血(MAA-202)。该公司的产品还包括一种皮下(SQ)因子IX(FIX)dalcinonacog alfa(DalcA),用于预防血友病B患者的出血事件。其发现阶段的因子IX基因治疗构建体CB 2679d-GT用于血友病B。

微牛提供Catalyst Biosciences Inc(NASDAQ-CBIO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CBIO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CBIO股票基本功能。